mITT analysis showed no difference in proportion of therapeutical failure between treatment arms [ 67/209 ( 32 % ) in NVP vs. 63/216 ( 29 % ) LPV/r at week 48 ( P = 0.53 ) ; 88/209 ( 42 % ) in NVP vs. 83/216 ( 38 % ) in LPV/r at week 96 ( P = 0.49 ) ] .